Hearing Rehabilitation for Cognitive Impairment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to develop and test a hearing rehabilitation program specifically for individuals with cognitive impairment, such as Alzheimer's, using a new device and program called HEARS-SLP. The study will evaluate the effectiveness of this treatment when delivered by a speech-language pathologist. Participants will either begin the treatment immediately or after a one-month delay for comparison. Ideal participants are English-speaking individuals who live at home, have been diagnosed with Alzheimer's or related dementia, experience hearing loss, and have a caregiver who assists them regularly. As an unphased trial, this study provides a unique opportunity to contribute to innovative research in hearing rehabilitation for cognitive impairment.
Will I have to stop taking my current medications?
The trial requires that your medication dosage for neuropsychiatric symptoms be stable for at least 2 weeks, so you may not need to stop taking your current medications if they meet this condition.
What prior data suggests that the HEARS-SLP device and program are safe for individuals with cognitive impairment?
Research shows that specific safety information for the HEARS-SLP device or program is not yet available. Detailed studies have not yet determined its safety for individuals. The trial is in an early stage, so researchers are still assessing how participants might respond to the treatment. Early trials typically focus on evaluating a treatment's effectiveness and identifying any side effects. Those concerned about the treatment's safety should consult their doctor before deciding to join the trial.12345
Why are researchers excited about this trial?
Researchers are excited about the HEARS-SLP device and program because they offer a fresh approach to addressing cognitive impairment linked to hearing loss. Unlike traditional hearing aids that simply amplify sound, the HEARS-SLP system combines an innovative device with a specialized program to potentially enhance cognitive functions by improving auditory processing. This dual approach targets not only the hearing issues but also aims to directly boost cognitive health, which could be a game-changer compared to existing treatments that primarily focus on hearing improvement alone.
What evidence suggests that the HEARS-SLP device and program are effective for hearing rehabilitation in individuals with cognitive impairment?
Research shows that the HEARS-SLP treatment, which uses a device and a program, is specifically designed to address hearing and thinking problems. In this trial, participants will join either an immediate treatment arm or a delayed treatment arm. Previous studies on the HEARS model have shown that community-based programs can effectively support hearing health. By involving speech-language pathologists (SLPs) in delivering this treatment, the program aims to make hearing help more accessible and affordable. Early results suggest that using SLPs could enhance the program's effectiveness for individuals with thinking difficulties. This approach is expected to improve communication and overall quality of life for participants.12345
Who Is on the Research Team?
Esther Oh, MD, PhD
Principal Investigator
Johns Hopkins School of Medicine
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals aged 60-100 with probable Alzheimer's or related dementia, who live at home and have stable medication dosing. They must have adult-onset hearing loss and a caregiver available to assist with the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Immediate Treatment
Participants receive immediate hearing rehabilitative intervention delivered by a speech-language pathologist
Delayed Treatment
Participants receive delayed hearing rehabilitative intervention delivered by a speech-language pathologist after a 1-month delay
Follow-up
Participants are monitored for changes in neuropsychiatric symptoms and quality of life post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- HEARS-SLP device
- HEARS-SLP program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute on Aging (NIA)
Collaborator